C-reactive protein and substance use disorders in adolescence and early adulthood: A prospective analysis

Drug and Alcohol Dependence

Volumn 133, Issue 2, 2013, Pages 712-717

  Costello, E Jane ^a   Copeland, William E ^a   Shanahan, Lilly ^b   Worthman, Carol M ^c   Angold, Adrian ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Adolescence; CRP; Epidemiology; Inflammation; Substance use disorders

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; CANNABIS; NICOTINE;

ADOLESCENT; ADULT; AGE; ALCOHOL ABUSE; AMERICAN INDIAN; ARTICLE; CANNABIS ADDICTION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE; SCHOOL CHILD; STRUCTURED INTERVIEW; TOBACCO DEPENDENCE; UNITED STATES;

CANNABIS;

ADOLESCENCE; CRP; EPIDEMIOLOGY; INFLAMMATION; SUBSTANCE USE DISORDERS;

ADOLESCENT; AGE FACTORS; C-REACTIVE PROTEIN; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; OBESITY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84887025019     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.08.027     Document Type: Article

References (69)

1. Achenbach T.M. Manual for the Child Behavior Checklist 4-18 and 1991 Profile 1991, University of Vermont Department of Psychiatry, Burlington, VT.
2. Albert M.A., Glynn R.J., Ridker P.M. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003, 107:443-447.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Press Inc., Washington, DC. fourth ed.=
4. Angold A., Costello E. The Child and Adolescent Psychiatric Assessment (CAPA). J. Am. Acad. Child Adolesc. Psychiatry 2000, 39:39-48.
5. Angold A., Costello E.J. A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). Psychol. Med. 1995, 25:755-762.
6. Angold A., Cox A., Prendergast M., Rutter M., Simonoff E., Costello E.J., Ascher B.H. The Young Adult Psychiatric Assessment (YAPA) 1999, Duke University Medical Center, Durham NC.
7. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J. Autoimmun. 2010, 34:J258-J265.
8. Ascher B.H., Farmer E.M.Z., Burns B.J., Angold A. The Child and Adolescent Services Assessment (CASA): description and psychometrics. J. Emot. Behav. Disord. 1996, 4:12-20.
9. Benowitz N.L. Basic cardiovascular research and its implications for the medicinal use of nicotine. J. Am. Coll. Cardiol. 2003, 41:497-498.
10. Benson S., Arck P.C., Tan S., Mann K., Hahn S., Janssen O.E., Schedlowski M., Elsenbruch S. Effects of obesity on neuroendocrine, cardiovascular, and immune cell responses to acute psychosocial stress in premenopausal women. Psychoneuroendocrinology 2009, 34:181-189.
11. Black S., Kushner I., Samols D. C-reactive protein. J. Biol. Chem. 2004, 279:48487-48490.
12. Catanzaro D.F., Zhou Y., Chen R., Yu F., Catanzaro S.E., De Lorenzo M.S., Subbaramaiah K., Zhou X.K., Pratico D., Dannenberg A.J. Potentially reduced exposure cigarettes accelerate atherosclerosis: evidence for the role of nicotine. Cardiovasc. Toxicol. 2007, 7:192-201.
13. Copeland W.E., Shanahan L., Worthman C., Angold A., Costello E.J. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol. Psychiatry 2012, 71:15-21.
14. Copeland W.E., Shanahan L., Worthman C., Angold A., Costello E.J. Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. Psychol. Med. 2012, 1-10.
15. Costello E.J., Angold A., Burns B., Stangl D., Tweed D., Erkanli A., Worthman C. The Great Smoky Mountains Study of Youth: goals, designs, methods, and the prevalence of DSM-III-R disorders. Arch. Gen. Psychiatry 1996, 53:1129-1136.
16. Costello E.J., Mustillo S., Erkanli A., Keeler G., Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry 2003, 60:837-844.
17. Crimmins E.M., Finch C.E. Infection, inflammation, height, and longevity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:498-503.
18. Davey Smith G., Lawlor D.A., Harbord R., Timpson N., Rumley A., Lowe G.D., Day I.N., Ebrahim S. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1051-1056.
19. Elovainio M., Keltikangas-Jarvinen L., Pulkki-Raback L., Kivimaki M., Puttonen S., Viikari L., Rasanen L., Mansikkaniemi K., Viikari J., Raitakari O.T. Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychol. Med. 2006, 36:797-805.
20. Elovainio M., Keltikangas-Järvinen L., Pulkki-Råback L., Kivimäki M., Puttonen S., Viikari L., Räsänen L., Mansikkaniemi K., Viikari J., Raitakari O.T. Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychol. Med. 2006, 36:797-805.
21. Furie M.B., Raffanello J.A., Gergel E.I., Lisinski T.J., Horb L.D. Extracts of smokeless tobacco induce pro-inflammatory changes in cultured human vascular endothelial cells. Immunopharmacology 2000, 47:13-23.
22. Gimeno D., Kivimäki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., Kumari M., Lowe G.D.O., Rumley A., Marmot M.G., Ferrie J.E. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 2009, 39:413-423.
23. Gonçalves R., Coletta R., Silvério K.G. Impact of smoking on inflammation: overview of molecular mechanisms. Inflammation Research 2011, 60:409-424.
24. Hartman C.A., Gelhorn H., Crowley T.J., Sakai J.T., Stallings M., Young S.E., Rhee S.H., Corley R., Hewitt J.K., Hopfer C.J. Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:165-173.
25. Hastie C.E., Haw S., Pell J.P. Impact of smoking cessation and lifetime exposure on C-reactive protein. Nicotine Tob. Res. 2008, 10:637-642.
26. Heeschen C., Weis M., Cooke J.P. Nicotine promotes arteriogenesis. J. Am. Coll. Cardiol. 2003, 41:489-496.
27. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001, 357:763-767.
28. Janicki Deverts D., Cohen S., Dilillo V.G., Lewis C.E., Kiefe C., Whooley M., Matthews K.A. Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom. Med. 2010, 72:734-741.
29. Kelley K.W., Dantzer R. Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav. Immun. 2011, 25(Suppl. 1):S13-S20.
30. Kushner I., Samols D., Magrey M. A unifying biologic explanation for "high-sensitivity" C-reactive protein and "low-grade" inflammation. Arthritis Care Res. 2010, 62:442-446.
31. Lao X.Q., Jiang C.Q., Zhang W.S. Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study. Atherosclerosis 2009, 203:304-310.
32. Langenbucher J., Labouvie E., Martin C., Al E. An application of item response theory analysis to alcohol, cannabis, and cocaine criteria in DSM-IV. J. Abnorm. Psychol. 2004, 113:72-80.
33. Lee J., Taneja V., Vassallo R. Cigarette smoking and inflammation cellular and molecular mechanisms. J. Dent. Res. 2012, 91:142-149.
34. Lim S.M., Kim H.C., Lee H.S., Lee J.Y., Suh M., Ahn S.V. Association between blood pressure and carotid intima-media thickness. J. Pediatrics 2009, 154:667-671.
35. Macy E.M., Hayes T.E., Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 1997, 43:52-58.
36. Mao J., Liu J., Pang X., Li M., Song J., Han C., Wu D., Wang S. Nicotine induces the expression of C-reactive protein via MAPK-dependent signal pathway in U937 macrophages. Mol. Cells 2012, 34:457-461.
37. Matthews K.A., Schott L.L., Bromberger J.T., Cyranowski J.M., Everson-Rose S.A., Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women?. Brain Behav. Immun. 2010, 24:96-101.
38. Mcdade T.W., Burhop J., Dohnal J. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin. Chem. 2004, 50:652-654.
39. Mcdade T.W., Hawkley L.C., Cacioppo J.T. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago Health, Aging, and Social Relations Study. Psychosom. Med. 2006, 68:376-381.
40. Mcdade T.W., Leonard W.R., Burhop J., Reyes-García V., Vadez V., Huanca T., Godoy R.A. Predictors of C-reactive protein in Tsimane' 2 to 15 year-olds in lowland Bolivia. Am. J. Phys. Anthropol. 2005, 128:906-913.
41. Mcdade T.W., Williams S., Snodgrass J.J. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007, 44:899-925.
42. Mcdade W., Stallings J.F., Worthman C.M. Psychosocial stress and cell-mediated immune function: validation of a blood spot method for Epstein-Barr virus antibodies. American J. Phys. Anthropol. (Suppl.) 1997, 24:164-165.
43. Mei J.V., Alexander J.R., Adam B.W., Hannon W.H. Use of filter paper for the collection and analysis of human whole blood specimens. J. Nutr. 2001, 131:1631S-1636S.
44. Miller G.E., Chen E., Fok A.K., Walker H., Lim A., Nicholls E.F., Cole S., Kobor M.S. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14716-14721.
45. Miller G.E., Chen E., Parker J.K. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol. Bull. 2011, 137:959-997.
46. O'brien C.P., Volkow N., Li T.K. What's in a word? Addiction versus dependence in DSM-V. Am. J. Psychiatry 2006, 163:764-765.
47. O'connor M.-F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009, 23:887-897.
48. O'loughlin J., Lambert M., Karp I., Mcgrath J., Gray-Donald K., Barnett T.A., Delvin E.E., Levy E., Paradis G. Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. Nicotine Tob. Res. 2008, 10:525-532.
49. Pai J.K., Hankinson S.E., Thadhani R., Rifai N., Pischon T., Rimm E.B. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2006, 186:113.
50. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Iii Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Taubert K., Tracy R.P., Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
51. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
52. Rajavashisth T.B., Shaheen M., Norris K.C., Pan D., Sinha S.K., Ortega J., Friedman T.C. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. Br. Med. J. Open 2012, 2.
53. Reece A. High-sensitivity CRP in opiate addiction: relative and age-dependent elevations. Cardiovasc. Toxicol. 2012, 12:149-157.
54. Reece A.S. High-sensitivity CRP in opiate addiction: relative and age-dependent elevations. Cardiovasc. Toxicol. 2012, 1-9.
55. Reinehr T., Kiess W., De Sousa G., Stoffel-Wagner B., Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006, 55:113-118.
56. Rose J.E., Mukhin A.G., Lokitz S.J., Turkington T.G., Herskovic J., Behm F.M., Garg S., Garg P.K. Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine. Proc. Natl. Acad. Sci. 2010, 107:5190-5195.
57. Roy S., Ninkovic J., Banerjee S., Charboneau R., Das S., Dutta R., Kirchner V., Koodie L., Ma J., Meng J., Barke R. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J. Neuroimmune Pharmacol. 2011, 6:442-465.
58. Saha T.D., Chou S.P., Grant B.F. Toward an alcohol use disorder continuum using item response theory: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol. Med. 2006, 36:931-941.
59. Shah T., Casas J.P., Cooper J.A., Tzoulaki I., Sofat R., Mccormack V., Smeeth L., Deanfield J.E., Lowe G.D., Rumley A., Fowkes F.G.R., Humphries S.E., Hingorani A.D. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int. J. Epidemiol. 2009, 38:217-231.
60. Skinner A.C., Steiner M.J., Henderson F.W., Perrin E.M. Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. Pediatrics 2010, 125:e801-e809.
61. Stewart J.C., Rand K.L., Muldoon M.F., Kamarck T.W. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav. Immun. 2009, 23:936-944.
62. Villegas R., Xiang Y., Cai H., Elasy T., Cai Q., Zhang X., Fazio S., Linton M., Li H., Xu W. Lifestyle determinants of c-reactive protein in middle-aged, urban Chinese men. Nutr. Metab. Cardiovasc. Dis. 2012, 22:223-230.
63. Volanakis J.E. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 2001, 38:189-197.
64. Volkow N.D., Wang G.J., Fowler J.S., Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363:3191-3200.
65. Williams S.R., Mcdade T.W. The use of dried blood spot sampling in the National Social Life Health, and Aging Project. J. Gerontol. B: Psychol. Sci. Soc. Sci. 2009, 64B:i131-i136.
66. Woloshin S., Schwartz L.M. Distribution of C-reactive protein values in the United States. N. Engl. J. Med. 2005, 352:1611-1613.
67. Woodward M., Rumley A., Lowe G.D.O., Tunstall-Pedoe H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br. J. Haematol. 2003, 122:135-141.
68. Worthman C.M., Stallings J.F. Hormone measures in finger-prick blood spot samples: new field methods for reproductive endocrinology. Am. J. Phys. Anthropol. 1997, 103:1-21.
69. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., Wouters E.F. Systemic effects of smoking. Chest 2007, 131:1557-1566.